Begin main content

Open Calls for Patient Input

This page lists Common Drug Review (CDR) drug applications received by CADTH and the deadlines for filing patient group input for each drug. For more information about how to provide input, please visit the CDR Patient Input page

TBC (Etanercept (Subsequent Entry Biologic))

Indications: Ankylosing spondylitis, polyarticular juvenile idiopathic arthritis, rheumatoid arthritis

Call For Patient Input: January 5, 2017

Patient Input Closed: February 24, 2017

TBC (Brexpiprazole)

Indications: Schizophrenia

Call For Patient Input: January 4, 2017

Patient Input Closed: February 23, 2017

Dysport Therapeutic (abobotulinumtoxinA)

Indications: Cervical dystonia

Call For Patient Input: January 3, 2017

Patient Input Closed: February 22, 2017

Cerdelga (Eliglustat)

Indications: Gaucher disease

Call For Patient Input: December 15, 2016

Patient Input Closed: February 10, 2017

TBD (Glatiramer acetate)

Indications: Multiple Sclerosis, relapsing - remitting

Call For Patient Input: December 15, 2016

Patient Input Closed: February 10, 2017

TBC (Obeticholic Acid)

Indications: Primary biliary cholangitis

Call For Patient Input: November 24, 2016

Patient Input Closed: January 20, 2017